Aldara Cream
Utilised to manage abnormal epidermal cells to support skin restoration and alleviate localised skin lesions.
Aldara Cream details
- Alternative names
- imiquimod
- Therapeutic class
- Immune Response Modifier
- Pharmacological class
- Topical Antineoplastic
- Contraindications
- hypersensitivity to imiquimod
- Minor side effects
- erythema; skin peeling; dry skin
- Moderate side effects
- local burning; itching; oedema
- Serious side effects
- severe localised necrosis, requires immediate medical attention
- Dosage forms
- Cream
- Administration route
- Cutaneous use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Viatris
- Onset Time
- 2–4 weeks
- Duration
- 8–12 hours
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for adults and children over twelve years.
Patient summary
utilised to manage abnormal epidermal cells to support skin restoration and alleviate localised skin lesions.
Mechanism of action
Acts as a toll-like receptor agonist, stimulating local cytokine production to recruit cellular immune responses against lesions.
Pregnancy and breastfeeding
TGA Category C: Limited human data. Use with caution. Breastfeeding: Consult a doctor.
What you will receive
Aldara Cream is the originator brand name, made by Viatris. We use it to identify the medicine and are not affiliated with Viatris.
- The fulfilment partner confirms whether the exact brand or an equivalent containing Imiquimod is offered.
- The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
- Check the final product details at checkout before confirming an order.